| 參考文獻 | http://www.fhcrc.org/labs/hahn/methods/biochem_meth/biorad_assay.pdf
Sambrook , Joseph, Russell , David W , 1957- David William (2001) Molecular Cloning : A Laboratory Manual (Cold Spring Harbor, New York. : Cold Spring Harbor Laboratory Press) 3rd pp8.24 ppA8.40-A8.47
Pharmingen (1999). Baculovirus Expression Vector System Manual (San Diego: Pharmingen) 6th pp1-14 pp31-43
Qiagen (2001). Ni-NTA Magnetic Agarose Beads Handbook (Qiagen) pp7-12
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., and Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763-1767.
Babcock, G. J., Esshaki, D. J., Thomas, W. D., Jr., and Ambrosino, D. M. (2004). Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78, 4552-4560.
Boehm, M., and Nabel, E. G. (2002). Angiotensin-converting enzyme 2--a new cardiac regulator. N Engl J Med 347, 1795-1797.
Bosch, B. J., van der Zee, R., de Haan, C. A., and Rottier, P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77, 8801-8811.
Chang, Y. J., Liu, C. Y., Chiang, B. L., Chao, Y. C., and Chen, C. C. (2004). Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions. J Immunol 173, 7602-7614.
Chen, J., Miao, L., Li, J. M., Li, Y. Y., Zhu, Q. Y., Zhou, C. L., Fang, H. Q., and Chen, H. P. (2005). Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization. World J Gastroenterol 11, 6159-6164.
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., and Doerr, H. W. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361, 2045-2046.
De Clercq, E. (2004). Antiviral drugs in current clinical use. J Clin Virol 30, 115-133.
De Clercq, E. (2006). Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev Anti Infect Ther 4, 291-302.
Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., Berger, A., Burguiere, A. M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J. C., Muller, S., Rickerts, V., Sturmer, M., Vieth, S., Klenk, H. D., Osterhaus, A. D., Schmitz, H., and Doerr, H. W. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348, 1967-1976.
Eickmann, M., Becker, S., Klenk, H. D., Doerr, H. W., Stadler, K., Censini, S., Guidotti, S., Masignani, V., Scarselli, M., Mora, M., Donati, C., Han, J. H., Song, H. C., Abrignani, S., Covacci, A., and Rappuoli, R. (2003). Phylogeny of the SARS coronavirus. Science 302, 1504-1505.
Fouchier, R. A., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stohr, K., and Osterhaus, A. D. (2003). Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240.
Groneberg, D. A., Hilgenfeld, R., and Zabel, P. (2005). Molecular mechanisms of severe acute respiratory syndrome (SARS). Respir Res 6, 8.
Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., Butt, K. M., Wong, K. L., Chan, K. W., Lim, W., Shortridge, K. F., Yuen, K. Y., Peiris, J. S., and Poon, L. L. (2003). Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276-278.
Hamming, I., Timens, W., Bulthuis, M. L., Lely, A. T., Navis, G. J., and van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203, 631-637.
Ho, J. C., Ooi, G. C., Mok, T. Y., Chan, J. W., Hung, I., Lam, B., Wong, P. C., Li, P. C., Ho, P. L., Lam, W. K., Ng, C. K., Ip, M. S., Lai, K. N., Chan-Yeung, M., and Tsang, K. W.. (2003). High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168, 1449-1456.
Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., Fey, G. H., Gramberg, T., and Pohlmann, S. (2004a). Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun 319, 1216-1221.
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Uberla, K., Niedrig, M., and Pohlmann, S. (2004b). S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 78, 6134-6142.
Holmes, K. V. (2003). SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 111, 1605-1609.
Jones, B. M., Ma, E. S., Peiris, J. S., Wong, P. C., Ho, J. C., Lam, B., Lai, K. N., and Tsang, K. W. (2004). Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp Immunol 135, 467-473.
Klempner, M. S., and Shapiro, D. S. (2004). Crossing the species barrier--one small step to man, one giant leap to mankind. N Engl J Med 350, 1171-1172.
Koren, G., King, S., Knowles, S., and Phillips, E. (2003). Ribavirin in the treatment of SARS: A new trick for an old drug? Cmaj 168, 1289-1292.
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A. E., Humphrey, C. D., Shieh, W. J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., DeRisi, J., Yang, J. Y., Cox, N., Hughes, J. M., LeDuc, J. W., Bellini, W. J., and Anderson, L. J. (2003). A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348, 1953-1966.
Kuba, K., Imai, Y., and Penninger, J. M. (2006). Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol 6, 271-276.
Kuiken, T., Fouchier, R. A., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., Laman, J. D., de Jong, T., van Doornum, G., Lim, W., Ling, A. E., Chan, P. K., Tam, J. S., Zambon, M. C., Gopal, R., Drosten, C., van der Werf, S., Escriou, N., Manuguerra, J. C., Stohr, K., Peiris, J. S., and Osterhaus, A. D. (2003). Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263-270.
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., and Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454.
Marra, M. A., Jones, S. J., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., Cloutier, A., Coughlin, S. M., Freeman, D., Girn, N., Griffith, O. L., Leach, S. R., Mayo, M., McDonald, H., Montgomery, S. B., Pandoh, P. K., Petrescu, A. S., Robertson, A. G., Schein, J. E., Siddiqui, A., Smailus, D. E., Stott, J. M., Yang, G. S., Plummer, F., Andonov, A., Artsob, H., Bastien, N., Bernard, K., Booth, T. F., Bowness, D., Czub, M., Drebot, M., Fernando, L., Flick, R., Garbutt, M., Gray, M., Grolla, A., Jones, S., Feldmann, H., Meyers, A., Kabani, A., Li, Y., Normand, S., Stroher, U., Tipples, G. A., Tyler, S., Vogrig, R., Ward, D., Watson, B., Brunham, R. C., Krajden, M., Petric, M., Skowronski, D. M., Upton, C., and Roper, R. L. (2003). The Genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404.
Miura, H. S., Nakagaki, K., and Taguchi, F. (2004). N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein. J Virol 78, 216-223.
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., Yan, K. W., Chan, K. H., Tsang, N. C., Guan, Y., Yuen, K. Y., and Peiris, J. S. (2003). Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773-1778.
Peiris, J. S., Guan, Y., and Yuen, K. Y. (2004). Severe acute respiratory syndrome. Nat Med 10, S88-97.
Ren, X., Glende, J., Al-Falah, M., de Vries, V., Schwegmann-Wessels, C., Qu, X., Tan, L., Tschernig, T., Deng, H., Naim, H. Y., and Herrler, G. (2006). Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 87, 1691-1695.
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Penaranda, S., Bankamp, B., Maher, K., Chen, M. H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q., Wang, D., Erdman, D. D., Peret, T. C., Burns, C., Ksiazek, T. G., Rollin, P. E., Sanchez, A., Liffick, S., Holloway, B., Limor, J., McCaustland, K., Olsen-Rasmussen, M., Fouchier, R., Gunther, S., Osterhaus, A. D., Drosten, C., Pallansch, M. A., Anderson, L. J., and Bellini, W. J.. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-1399.
Shemetilo, I. G., and Mallabiu, G. A. (1975). [Treatment of patients with epicondylitis of the arm by means of novocaine electrophoresis, medium frequency rectified sinusoidal currents, and centimeter band microwaves]. Vopr Kurortol Fizioter Lech Fiz Kult, 369-370.
Spiga, O., Bernini, A., Ciutti, A., Chiellini, S., Menciassi, N., Finetti, F., Causarono, V., Anselmi, F., Prischi, F., and Niccolai, N. (2003). Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem Biophys Res Commun 310, 78-83.
Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H. D., and Rappuoli, R. (2003). SARS--beginning to understand a new virus. Nat Rev Microbiol 1, 209-218.
Wang, P., Chen, J., Zheng, A., Nie, Y., Shi, X., Wang, W., Wang, G., Luo, M., Liu, H., Tan, L., Song, X., Wang, Z., Yin, X., Qu, X., Wang, X., Qing, T., Ding, M., and Deng, H. (2004). Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun 315, 439-444.
Wong, C. K., Lam, C. W., Wu, A. K., Ip, W. K., Lee, N. L., Chan, I. H., Lit, L. C., Hui, D. S., Chan, M. H., Chung, S. S., and Sung, J. J. (2004a). Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136, 95-103.
Wong, S. K., Li, W., Moore, M. J., Choe, H., and Farzan, M. (2004b). A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279, 3197-3201.
Wu, C. J., Jan, J. T., Chen, C. M., Hsieh, H. P., Hwang, D. R., Liu, H. W., Liu, C. Y., Huang, H. W., Chen, S. C., Hong, C. F., Lin, R. K., Chao, Y. S., and Hsu, J. T. (2004a). Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob Agents Chemother 48, 2693-2696.
Wu, C. Y., Jan, J. T., Ma, S. H., Kuo, C. J., Juan, H. F., Cheng, Y. S., Hsu, H. H., Huang, H. C., Wu, D., Brik, A., Liang, F. S., Liu, R. S., Fang, J. M., Chen, S. T., Liang, P. H., and Wong, C. H. (2004b). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 101, 10012-10017.
Xiao, X., Chakraborti, S., Dimitrov, A. S., Gramatikoff, K., and Dimitrov, D. S. (2003). The SARS-CoV S glycoprotein: expression and functional characterization. Biochem Biophys Res Commun 312, 1159-1164.
Xu, Y., Liu, Y., Lou, Z., Qin, L., Li, X., Bai, Z., Pang, H., Tien, P., Gao, G. F., and Rao, Z. (2004). Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem 279, 30514-30522.
Yuan, K., Yi, L., Chen, J., Qu, X., Qing, T., Rao, X., Jiang, P., Hu, J., Xiong, Z., Nie, Y., Shi, X., Wang, W., Ling, C., Yin, X., Fan, K., Lai, L., Ding, M., and Deng, H. (2004). Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem Biophys Res Commun 319, 746-752.
Zhang, R., Guo, Z., Lu, J., Meng, J., Zhou, C., Zhan, X., Huang, B., Yu, X., Huang, M., Pan, X., Ling, W., Chen, X., Wan, Z., Zheng, H., Yan, X., Wang, Y., Ran, Y., Liu, X., Ma, J., Wang, C., and Zhang, B. (2003). Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA. Chin Med J (Engl) 116, 1262-1264.
Zhang, Y., Li, J., Zhan, Y., Wu, L., Yu, X., Zhang, W., Ye, L., Xu, S., Sun, R., Wang, Y., and Lou, J. (2004). Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 72, 4410-4415.
Zhaori, G. (2003). Antiviral treatment of SARS: can we draw any conclusions? Cmaj 169, 1165-1166.
Ziebuhr, J. (2004). Molecular biology of severe acute respiratory syndrome coronavirus. Curr Opin Microbiol 7, 412-419.
|
|---|
